Your browser doesn't support javascript.
loading
Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.
Sakamoto, Hikaru; Ando, Koji; Imaizumi, Yoshitaka; Mishima, Hiroyuki; Kinoshita, Akira; Kobayashi, Yuji; Kitanosono, Hideaki; Kato, Takeharu; Sawayama, Yasushi; Sato, Shinya; Hata, Tomoko; Nakashima, Masahiro; Yoshiura, Koh-Ichiro; Miyazaki, Yasushi.
Affiliation
  • Sakamoto H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Ando K; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Imaizumi Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Mishima H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Kinoshita A; Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kobayashi Y; Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kitanosono H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kato T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Sawayama Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Sato S; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Hata T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Nakashima M; Department of Clinical Laboratory, Nagasaki Harbor Medical Center, Nagasaki, Japan.
  • Yoshiura KI; Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Miyazaki Y; Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Cancer Sci ; 113(12): 4092-4103, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36047964
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia-Lymphoma, Adult T-Cell / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia-Lymphoma, Adult T-Cell / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Country of publication: